Prioritised investments from pharma companies shaping competitive pipeline landscape of… GlobalData Jul 11, 2024 In recent years, bronchiectasis has garnered a significant amount of attention, with pharmaceutical companies prioritising their…
Australia’s CSL names insider Paul McKenzie as CEO EP News Bureau Dec 13, 2022 CSL makes most of its money paying people in the United States (US) for blood plasma, which it uses for treatments of rare…
Australia’s star vaccine maker not immune to virus anxiety: Analysis Reuters Oct 28, 2020 while the coronavirus pandemic has lifted CSL Ltd's investment profile, virus anxieties are also hitting its most lucrative…
Australia’s CSL says to help fund, make vaccine candidate if it proves successful Reuters Jun 5, 2020 Early pre-clinical results for the vaccine candidate have shown it produced high levels of antibodies that can neutralise the…